Lycopodium Clavatum.
Research-backed fatty acid with potential health benefits. Used in homeopathy for digestive and liver issues. No evidence at homeopathic dilutions.
Reviewed March 2026
- Category
- Fatty acid
What Lycopodium Clavatum is, and what it does.
- Does it work
- It suits people working inside a traditional or homeopathic system that names this plant. Anyone drawn by the acetylcholinesterase chemistry is thinking of huperzine A, a different species.
- How much to take
- Start with 100mg to 250mg a day of the herbal preparation, the daily maintenance band. The 500mg seen in research is a study condition. A homeopathic dilution is a different product.
- Time to feel it
- As a spore powder it acts as a flow and coating aid the moment it's blended, with no onset of its own. Nobody has measured a timeline for the herbal preparation.
- The first dose
- Day one is quiet. The spore powder is hydrophobic and free flowing, working as a coating and flow aid straight away, while the herb has no measured day-one effect.
- With regular use
- Weeks of daily use have not been measured in people. What is documented over time is the spore shell's use as a microcapsule, not a human daily-use record.
- How well tolerated
- Generally considered well tolerated at normal doses.
- How it feels
- The spore powder is dry, fine and slippery to handle, and tasteless inside a capsule. Most people report no distinct sensation from the herbal preparation.
- The overlooked benefit
- The emptied spore shell is sporopollenin, tough enough to shrug off acid and enzymes, and researchers use those hollow shells as natural microcapsules for carrying oils.
100 to 250mg a day is where Lycopodium Clavatum works.
Source: Homeopathic Materia Medica references; traditional herbal medicine
The proof, claim by claim.
These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.
Lycopodium Clavatum is documented in the library; the clinical read is in the queue. Nothing about the strength of the research prints until the read is done.
- emptied spore shells as an encapsulation materialIn vitro study
- use as a flow aid and dusting powder in tablet makingNarrative review
- acetylcholinesterase inhibition by clubmoss family alkaloidsIn vitro study
- antioxidant activity of clubmoss extractsIn vitro study
- traditional and homeopathic use for digestive comfortNarrative review
Questions people ask about Lycopodium Clavatum.
- When should I take it?
- Timing matters less than consistency. Pick a time that works for you and take it daily.
- Can I take it with other supplements?
- Usually fine. The main thing to watch is not doubling up on the same ingredient from different products. If you're on prescription meds, check with your pharmacist first.
- Any side effects to watch for?
- Most people tolerate it well at recommended doses. GI upset is the most common complaint with any supplement. Start with a lower dose and work up. If something feels off, stop and reassess.
Why these belong in the same formula. Each row says what the basis is, from settled biochemistry through to a trial that measured the pair.
Lycopodium alkaloids as a class show acetylcholinesterase-inhibiting activity, and huperzine A is the most potent member of that same family. Combining a club moss preparation with isolated huperzine A means the cholinergic effect adds, so total alkaloid load matters.
Alpha-GPC delivers choline for acetylcholine synthesis while Lycopodiaceae alkaloids slow the enzyme that breaks acetylcholine down. Substrate and clearance sit at opposite ends of the same synapse.
Choline is the rate-limiting precursor for acetylcholine synthesis, and cholinesterase-inhibiting alkaloids only help where there is transmitter to conserve. Adequate choline is the background condition for that mechanism.
Bacopa is placed alongside Lycopodiaceae-derived material in blends aimed at memory and focus. Their proposed routes differ, with bacosides studied for synaptic and antioxidant effects and Lycopodium alkaloids for cholinesterase activity in laboratory work. No study has examined the two together, and the alkaloid content of Lycopodium clavatum itself is not standardised.
Ginkgo is studied for cerebral blood flow and platelet-activating factor antagonism, a different route from cholinergic signalling. The two are combined in memory blends on that complementarity. No combination evidence exists, and ginkgo's own effect on platelet function matters for anyone on anticoagulant or antiplatelet medication.
Citicoline provides choline, the substrate that choline acetyltransferase joins to acetyl-CoA to make acetylcholine. Where a Lycopodiaceae alkaloid is intended to slow acetylcholine breakdown, a precursor addresses the other side of the same balance. The pairing is mechanistically coherent and untested as a combination, and Lycopodium clavatum is not a standardised alkaloid source.
Phosphatidylserine is a structural phospholipid of neuronal membranes and is placed in the same product category. Its route is structural rather than cholinergic. The pairing is conventional rather than studied.
Acetylcholine is built by transferring an acetyl group from acetyl-CoA onto choline, and coenzyme A is made from pantothenic acid. Pantothenate therefore sits upstream of the acetyl half of the molecule while choline supplies the other half. This is settled biochemistry, and it does not by itself mean supplementation raises acetylcholine in a person with adequate intake.
Acetyl-L-carnitine carries an acetyl group that can be transferred to coenzyme A through carnitine acetyltransferase, feeding the same acetyl pool acetylcholine synthesis draws on. It is combined with cholinergic agents on that reasoning. The step from acetyl-CoA supply to measurable acetylcholine change in people is not established.
Cleaned Lycopodium clavatum spore shells are hollow, uniform in size and chemically resistant, which is why they have been studied as natural microcapsules for oils. An oil such as MCT can be drawn into the emptied shell under vacuum. This is a delivery use of the spore wall, entirely separate from any biological activity of the plant.
Spore exine capsules from Lycopodium clavatum have been loaded with poorly water-soluble compounds, curcumin among them, in published encapsulation work. The shell protects the payload and disperses in water more readily than the raw powder. This is laboratory formulation research, and it says nothing about what the loaded material then does in a person.
Spore exine capsules have been used to encapsulate fish and cod liver oil, where the wall limits oxygen contact and masks taste. The loading is passive, driven by capillary action into the hollow shell. Again this is the spore wall acting as packaging, not as an active ingredient.
Nothing specific on file for Lycopodium Clavatum. Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.What Lycopodium Clavatum actually does.
Lycopodium clavatum is a clubmoss, a spore-bearing vascular plant, and the material sold as lycopodium powder is its dried spores rather than an extract of the plant body.
The spore wall is made of sporopollenin, a chemically resistant biopolymer that withstands acids, bases and enzymatic attack, which is why the emptied shells are studied as microcapsules and why fossil spores survive in sediment.
Lycopodium spores are uniform in size, hydrophobic and free flowing, which made them a traditional dusting powder, pill-coating agent and flow aid before synthetic excipients existed.
Alkaloid content in wild-harvested clubmoss varies with species, plant part, season and geography, so a product labelled Lycopodium clavatum carries no defined alkaloid dose unless it states a standardised assay.
Where Lycopodium Clavatum comes from.
Clubmoss is picked from forest floors, not farmed, because it grows very slowly. The yellow powder is its spores, shaken out and sieved. Tinctures are made by soaking the stems in alcohol instead. Homeopathic versions start from that tincture and are diluted over and over, which is a completely different product from the herb.
Made from a plant. What ends up in the capsule tracks the harvest, so batch testing and a stated marker matter more here than with a made molecule.
Lycopodium clavatum is gathered from temperate and boreal forest floors and heathland. It is slow growing and not cultivated at scale, so supply depends on wild collection and several regions restrict harvesting.
Ripe sporangia are shaken or beaten over cloth and the released spores are sieved through fine mesh to separate them from plant fragments, giving the pale yellow lycopodium powder.
For liquid preparations the aerial parts, rather than the spores, are macerated in an ethanol and water mixture for a set period and then pressed and filtered.
To make hollow capsules, spores are defatted with organic solvent, treated with alkali to remove protein, and with acid to hydrolyse the internal cellulose layer, leaving the sporopollenin wall. How completely the protein is removed determines the residual allergenic load.
Spore powder is specified by particle size and moisture. Tinctures are specified by plant to solvent ratio. Homeopathic products are specified by potency number rather than by any measured constituent.
Packed as loose powder, encapsulated, bottled as a tincture with a dropper, or dosed onto sucrose or lactose pillules for homeopathic use.
Harvest region, species verification and whether a product is the spore or the aerial part are frequently absent from labels, and no alkaloid assay is typically declared.
Getting Lycopodium Clavatum from food.
The whole-food sources on file. A supplement closes the gap, it does not replace dinner.
A gram-for-gram figure (how much of each you would eat to match a dose) will appear here once it is sourced and reviewed. This page will not print a number it cannot cite.
The forms it comes in.
Problems people have reported.
Read this carefully. These are 16,122 voluntary, unverified reactions reported to the FDA (openFDA). The number mostly reflects how popular Lycopodium Clavatum is, not how risky it is. A report is not proof Lycopodium Clavatum caused anything. It is a signal of what to watch for, nothing more.
Source: openFDA adverse-event reports. Voluntary reporting, not an incidence rate.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.